New hope for blood cancer patients: gentler treatment trial seeks to control disease
Disease control
Recruiting now
This study is testing whether a combination of two drugs, venetoclax and rituximab, works better than standard chemotherapy for people newly diagnosed with Waldenström's macroglobulinemia, a rare blood cancer. The goal is to see if this chemotherapy-free approach can control the …
Phase: PHASE2 • Sponsor: Christian Buske • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC